Paradigm Asset Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,400
Closed -$346K 513
2017
Q2
$346K Sell
5,400
-5,500
-50% -$339K 0.07% 289
2017
Q1
$628K Buy
10,900
+200
+2% +$11.9K 0.12% 215
2016
Q4
$655K Sell
10,700
-300
-3% -$19.5K 0.13% 164
2016
Q3
$761K Sell
11,000
-800
-7% -$52.8K 0.13% 131
2016
Q2
$657K Buy
11,800
+400
+4% +$24.1K 0.11% 177
2016
Q1
$692K Hold
11,400
0.13% 142
2015
Q4
$728K Sell
11,400
-25,600
-69% -$1.66M 0.13% 151
2015
Q3
$2.48M Sell
37,000
-8,400
-19% -$594K 0.32% 96
2015
Q2
$3.1M Hold
45,400
0.35% 95
2015
Q1
$2.52M Sell
45,400
-4,600
-9% -$236K 0.28% 124
2014
Q4
$2.56M Buy
+50,000
New +$2.46M 0.33% 112
2014
Q2
Sell
-1,700
Closed -$64K 846
2014
Q1
$64K Hold
1,700
0.01% 661
2013
Q4
$64.2K Hold
1,700
0.01% 650
2013
Q3
$73.8K Buy
+1,700
New +$68.2K 0.01% 609

Other funds holding USNA

Paradigm Asset Management's USNA Position: Q3 2017 in Review

Paradigm Asset Management sold out of Usana Health Sciences (USNA) in Q3 2017, closing a stake of 5,400 shares — an estimated $346K sold.

Paradigm Asset Management first reported a position in USNA in Q3 2013 and held it in 14 quarters. The position peaked at $3.1M in Q2 2015. 144 funds tracked by Wall St. Rank hold USNA as of Q3 2017.

  • Paradigm Asset Management reported no remaining Usana Health Sciences position as of Q3 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 5,400 Usana Health Sciences shares in Q3 2017, an estimated $346K.
  • Paradigm Asset Management first reported a position in Usana Health Sciences in Q3 2013 and held it in 14 quarters.
  • Paradigm Asset Management's Usana Health Sciences position peaked at $3.1M in Q2 2015.
  • 144 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2017.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.